Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.

Investlytic score: 1/5 criteria met. Data as of 01/11/2026.
- ❌ Price trend failed
- ⚠️ Mixed growth
- ❌ Debt failed
- ❌ P/E failed
- ✅ Correction passed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2018 → 2019: 23.42%
Price change 2019 → 2020: -12.30%
Price change 2020 → 2021: 19.38%
Price change 2021 → 2022: -30.53%
Price change 2022 → 2023: -21.02%
Price change 2023 → 2024: 2.37%
Price change 2024 → 2025: -20.67%
Price change 2025 → 2026: 19.19%
Price change 2026 (year to date): 18.30%
Financial growth
Revenue CAGR (8 years): 13.11%
Earnings CAGR (8 years): -32.00%
Growth status: positive trend (>1%/yr) in revenue OR earnings, but not both.
Debt
Debt-to-equity ratio: 1.39
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 54.84
P/E > 25.0 (maximum threshold).
Correction (6 months)
Current correction: 16.02% from the high over 6 months.
Correction between 10.0% and 20.0% (target range).
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="DOC" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| Healthpeak Properties, Inc. | 57.9 | 1.39 | +3.7 % | 🔒 |
| Unibail-Rodamco-Westfield SE | 8.3 | 1.38 | +4.9 % | – |
| Vonovia SE | 3.8 | 1.58 | +10.2 % | – |
| Klépierre | 7.7 | 0.94 | +4.7 % | – |
| AGNC Investment Corp. | 5.8 | 8.21 | +11.8 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Key reported figures
Revenue, net income and net margin reported by Healthpeak Properties, Inc. over the latest fiscal years.
| Fiscal year | Revenue | Net income | Net margin | Revenue growth |
|---|---|---|---|---|
| 2020 | 1.6 bn | 414 m | 25.1 % | n/a |
| 2021 | 1.9 bn | 506 m | 26.7 % | +15.3 % |
| 2022 | 2.1 bn | 500 m | 24.3 % | +8.7 % |
| 2023 | 2.2 bn | 306 m | 14.0 % | +5.8 % |
| 2024 | 2.7 bn | 243 m | 9.0 % | +23.8 % |
| 2025 | 2.8 bn | 71.3 m | 2.5 % | +4.5 % |
Amounts converted to USD. Source: published annual accounts, collected on 13/11/2026.
Accounts and financial health
Balance sheet and cash flow published by Healthpeak Properties, Inc. over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash and investments | 158 m | 72.0 m | 118 m | 120 m | 538 m |
| Total Debt | 6.4 bn | 6.7 bn | 7.1 bn | 9.0 bn | 10.4 bn |
| Net Debt | 6.2 bn | 6.6 bn | 7.0 bn | 8.9 bn | 9.9 bn |
| Equity | 6.5 bn | 6.7 bn | 6.4 bn | 8.4 bn | 7.5 bn |
| Total assets | 15.3 bn | 15.8 bn | 15.7 bn | 19.9 bn | 20.3 bn |
| Operating cash flow | 795 m | 900 m | 956 m | 1.1 bn | 1.3 bn |
| Investments (capex) | 0 | 0 | 0 | 0 | 0 |
| Free cash-flow | 795 m | 900 m | 956 m | 1.1 bn | 1.3 bn |
| Share buybacks | 12.8 m | 67.8 m | 6.5 m | 191 m | 97.1 m |
| Dividends paid | 650 m | 648 m | 657 m | 795 m | 849 m |
Amounts in USD, currency of the published accounts.
Trailing 12-month ratios
Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 16/11/2026.
Valuation and competitors
Healthpeak Properties, Inc. compared with its sector on the same exchange and with its main competitors.
Direct competitors
| Company | Market cap (USD) | P/E | Net margin |
|---|---|---|---|
| Healthpeak Properties, Inc. | 13.8 bn | 57.1 | 2.5 % |
| Omega Healthcare Investors, Inc. OHI | 14.3 bn | 16.1 | 49.2 % |
| CareTrust REIT, Inc. CTRE | 9.8 bn | 24.4 | 67.3 % |
| Sabra Health Care REIT, Inc. SBRA | 5.4 bn | 77.4 | 20.1 % |
| American Healthcare REIT, Inc. AHR | 13.4 bn | 85.0 | 3.1 % |
| LTC Properties, Inc. LTC | 2.4 bn | 16.0 | 44.9 % |
| National Health Investors, Inc. NHI | 3.1 bn | 17.9 | 37.6 % |
| Welltower Inc. WELL | 179 bn | 105.8 | 8.8 % |
| Sector median (NYSE) | 44.1 |
Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 11/11/2026. Competitors: comparable companies named by the data provider.
Analyst consensus and forecasts
What the financial analysts covering Healthpeak Properties, Inc. publish: ratings, price targets and earnings forecasts.
Breakdown of ratings
Analysts' average target 22.00 USD, DCF value 33.34 USD, share price 20.26 USD.
Average target over the last 3 months: 21.50 USD (4 targets).
Analyst forecasts
| Fiscal year | Revenue | Net income | Expected EPS (range) | P/E on this EPS | Analysts |
|---|---|---|---|---|---|
| 2026 | 3.0 bn | 319 m | 0.46 (0.45 / 0.46) | 43.9 | 2 |
| 2027 | 3.1 bn | 154 m | 0.22 (0.21 / 0.23) | 91.8 | 4 |
| 2028 | 3.4 bn | 202 m | 0.29 (0.26 / 0.31) | 69.8 | 2 |
Amounts in USD, the reporting currency.
Track record against expectations: reported EPS above consensus 6 times over the last 12 releases.
Rating changes (12 months)
| Date | Firm | Before | After |
|---|---|---|---|
| 11/11/2026 | UBS | Neutral | Neutral |
| 06/11/2026 | Evercore ISI Group | In Line | In Line |
| 04/11/2026 | Cantor Fitzgerald | Neutral | Neutral |
| 19/10/2026 | Wells Fargo | Equal Weight | Equal Weight |
| 13/10/2026 | UBS | Neutral | Neutral |
Source: ratings and forecasts published by analysts, collected on 14/11/2026. An analyst rating or target is not a guarantee.
Who owns the stock
Free float, institutional investors, large funds, executives and elected officials: declared positions in Healthpeak Properties, Inc.
Indices: S&P 500 (since 31/03/2008).
Large funds tracked
| Fund | Shares | Value (USD) | Weight in the fund | Change | Quarter |
|---|---|---|---|---|---|
| State Street | 88.0 m | 1.9 bn | 0.0 % | +81.5 % | 2026Q2 |
| Vanguard Group | 109 m | 1.8 bn | 0.0 % | -0.3 % | 2025Q4 |
| BlackRock | 70.9 m | 1.5 bn | 0.0 % | -3.3 % | 2026Q2 |
| JPMorgan Chase | 30.2 m | 661 m | 0.0 % | -32.5 % | 2026Q2 |
| Geode Capital Management | 24.7 m | 527 m | 0.0 % | +1.0 % | 2026Q2 |
| Invesco | 18.5 m | 396 m | 0.0 % | -23.4 % | 2026Q2 |
| Morgan Stanley | 14.2 m | 304 m | 0.0 % | +15.3 % | 2026Q2 |
| Goldman Sachs | 11.5 m | 247 m | 0.0 % | +59.2 % | 2026Q2 |
Latest insider transactions
| Date | Person | Side | Amount |
|---|---|---|---|
| 09/11/2026 | Patadia Ankit B. | sale | 127,070 USD |
Elected officials' disclosures
| Date | Official | Side | Amount |
|---|---|---|---|
| 27/03/2026 | Alan Armstrong | purchase | $1,001 - $15,000 |
| 09/01/2026 | Gilbert Cisneros | purchase | $1,001 - $15,000 |
Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 16/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.
PEA and practical information
Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.
Frequently asked questions about Healthpeak Properties, Inc.
What is the Healthpeak Properties, Inc. share price?
Latest recorded price: 19.98 USD on 13/11/2026, for a market cap of 13.8 bn USD.
What is the revenue of Healthpeak Properties, Inc.?
2.8 bn USD for fiscal year 2025, with net income of 71.3 m USD (net margin 2.5 %).
When does Healthpeak Properties, Inc. report its next earnings?
The next release is expected on 01/02/2027. EPS expected by analysts: 0.04.
What do analysts say about Healthpeak Properties, Inc.?
Out of 41 analysts: 19 buy or strong buy, 22 hold, 0 sell or strong sell. Average price target: 22.00 USD, i.e. +8.6 % from the share price.
What is the P/E ratio of Healthpeak Properties, Inc.?
Trailing 12-month P/E of 57.1, against 44.1 for the sector median on the same exchange (10-year median: 42.7).
Is Healthpeak Properties, Inc. stock eligible for the French PEA?
No: the company is headquartered outside the European Union and the European Economic Area (ISIN US42250P1030).
How many employees does Healthpeak Properties, Inc. have?
387 full-time employees according to the latest published profile.
Who runs Healthpeak Properties, Inc.?
Scott M. Brinker is the company's chief executive.
Which large funds own Healthpeak Properties, Inc.?
As of 2026Q2, among the large funds tracked: State Street, Vanguard Group, BlackRock, JPMorgan Chase, Geode Capital Management.